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Background: Cyclophilin A (CypA), a member of the immunophilin family, is a ubiquitously distributed intracellular
protein. Recent studies have shown that CypA is secreted by cells in response to inflammatory stimuli. Elevated
levels of extracellular CypA and its receptor, CD147 have been detected in the synovium of patients with RA.
However, the precise process of interaction between CypA and CD147 in the development of RA remains unclear.
This study aimed to investigate CypA secretion from fibroblast-like synoviocytes (FLS) isolated from mice with
collagen-induced arthritis (CIA) and CypA-induced CD147 expression in mouse macrophages.
Findings: CIA was induced by immunization with type II collagen in mice. The expression and localization of CypA
and CD147 was investigated by immunoblotting and immunostaining. Both CypA and CD147 were highly
expressed in the joints of CIA mice. CD147 was expressed in the infiltrated macrophages in the synovium of CIA
mice. In vitro, spontaneous CypA secretion from FLS was detected and this secretion was increased by stimulation
with lipopolysaccharide. CypA markedly increased CD147 levels in macrophages.
Conclusions: These findings suggest that an interaction in the synovial joints between extracellular CypA and
CD147 expressed by macrophages may be involved in the mechanisms underlying the development of arthritis.
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Rheumatoid arthritis (RA) is an autoimmune inflamma-
tory disease characterized by synovial hyperplasia and
articular cartilage degradation. The hyperplasia of the
synovial lining is largely composed of increased number
of fibroblast-like synoviocytes (FLS) and macrophages.
FLS play a critical role in RA pathogenesis by inducing
the inflammatory microenvironment in the synovial
joints through production of pro-inflammatory factors
or recruitment of other immune cells. Macrophages are
localized in the synovial lining with FLS, where they* Correspondence: ykataoka@fukuoka-u.ac.jp
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reproduction in any medium, provided the ormodulate the function of each other through surface
molecules as well as soluble mediators [1].
Cyclophilin A (CypA), the most abundant cytoplasmic
cyclophilin, has been identified as the intracellular bind-
ing protein for the immunosuppressive drug cyclospor-
ine A [2,3]. Although CypA was initially shown to
function primarily as an intracellular protein, recent
studies have shown that it can be secreted by cells in re-
sponse to inflammatory stimuli [4-8]. Elevated levels of
extracellular CypA have been detected in the synovial
fluid of patients with RA [9]. CD147 is a cell surface
glycoprotein that belongs to the immunoglobulin super-
family and was identified as the signaling receptor for
extracellular CypA [10]. CD147 is also known as EMM-
PRIN (extracellular matrix metalloproteinase inducer),
and the expression of CD147 stimulates the productionl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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pression of CD147 has been shown in patients with RA
[12,13]. Recent experimental finding suggests that
CypA-CD147 interactions may be associated with the re-
cruitment of leucocytes into the joint tissues [14]. How-
ever, the precise process of interaction between CypA
and its receptor CD147 in the development of RA
remains unclear.
In the present study, we demonstrated that both CypA
and CD147 are highly expressed in the joints of mice
with collagen-induced arthritis (CIA). CypA was released
from FLS, and increased CD147 expression in macro-
phages. These findings suggest that an interaction in the
synovial joints between extracellular CypA and CD147
expressed by macrophages forms one of the critical
mechanisms underlying the pathogenesis of RA.
Methods
Animals
Six-week-old male DBA/1J and C57BL/6N mice were
purchased from Kyudo (Tosu, Japan). All the procedures
involving experimental animals adhered to the law (No.
105) and notification (No. 6) of the Japanese Govern-
ment, and were approved by the Laboratory Animal
Care and Use Committee of Fukuoka University.
Induction of CIA in mice
Bovine type II collagen (CII) (Chondrex) was emulsified
with an equal volume of complete Freund’s adjuvant
(Chondrex) to give a final concentration of 1 mg/mL.
DBA/1J mice were immunized intradermally at the base
of the tail with 100 μg emulsified CII. Age-matched
DBA/1J mice without CIA were employed as controls.
The severity of arthritis was graded on a 0–4 scale, as
previously described [15]. Mice showing scale 4 in the
severity of arthritis were supplied for the following
experiments.
Isolation of FLS from CIA mice
Mouse FLS were isolated from the tarsus of the hind paws
of CIA mice. After careful removal of the skin, joints were
minced and digested for 2 h at 37°C in Dulbecco’s modi-
fied Eagle’s medium (DMEM) containing collagenase type
4 and DNase. After filtration through a 100-μm cell
strainer, cell suspension was collected, centrifuged, resus-
pended, and cultured in DMEM supplemented with 10%
fetal bovine serum (FBS). Cultured mouse FLS at 80–90%
confluency in a dish (6 cm in diameter) were used for
in vitro assays from passage 3 to 7.
Isolation of bone marrow-derived macrophages from
mice
C57BL/6N mice were euthanized, and the femur and
tibia of the hind legs were dissected. Bone marrowcavities were flushed with Minimum Essential Medium
(MEM)-α. The bone marrow cells were cultured in
MEM-α supplemented with 10% FBS, 20 ng/mL
macrophage-colony stimulating factor (Sigma) for 5 days.
Before use, bone marrow-derived macrophages were
washed vigorously to remove nonadherent cells.Immunohistochemistry of synovial tissues of control and
CIA mice
The ankle joints were fixed in 4% paraformaldehyde and
decalcified until the bones were pliable. Sagittal sections
were prepared on a cryostat. The sections were incu-
bated with anti-CypA (Proteintech Group), anti-CD147
(Abcam) and anti-CD11b (Thermo Fisher Scientific)
antibodies. After incubation with primary antibodies, the
sections were further incubated with peroxidase-
conjugated anti-rabbit IgG secondary antibody. Color
was developed using the DAKO Liquid DAB + Substrate
Chromogen System (Dako North America), followed by
counterstaining with hematoxylin. The sections of CIA
mice were stained according to the method described
above, except that the primary antibody was omitted.
Weak non-specific staining was observed (negative con-
trol in Figures 1b and 2b).
For double immunofluorescence staining, the sections
were incubated with a combination of rat anti-CD147
(AbD Serotec) and rabbit anti-CD11b antibodies. Cy3-
conjugated anti-rat IgG and fluorescein isothiocyanate
(FITC)-conjugated anti-rabbit IgG antibodies were used
as secondary antibodies. The sections of CIA mice were
stained according to the method described above, except
that the primary antibodies were omitted. Non-specific
staining was almost null (negative control in Figure 2c).
Images were captured using Confocal microscope
(OLYMPUS).Immunoblot analysis of CypA and CD147
Mice were anesthetized with sodium pentobarbital and
decapitated. The ankle joints were frozen with liquid ni-
trogen, crushed, and lysed in RIPA buffer. Mouse FLS
and macrophages were washed with PBS and lysed in
RIPA buffer. Conditioned media from FLS were concen-
trated using an Amicon Ultra-50k and 10k centrifugal
filters (Millipore). Denatured lysates and concentrated
conditioned media were separated by SDS-PAGE and
transferred to polyvinylidene difluoride membranes. The
membranes were immunoblotted with anti-CypA, anti-
CD147, anti-glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) (EPITOMICS) and anti-β-actin (IMGENEX)
antibodies. Immunoblots were then exposed to
peroxidase-conjugated secondary antibodies and visua-
lized using a SuperSignal West Femto Maximum Sensi-































Figure 1 CypA expression in synovial tissues and CypA secretion from FLS of CIA mice. (a) Representative western blots of CypA levels in
the lysates obtained from synovial tissues of control and CIA mice. Protein levels of CypA were normalized to GAPDH and the data are expressed
as the percentage of control values. Three separate experiments (n = 3 mice in each) were performed (control: 100.0 ± 4.4%, CIA: 668.0 ± 22.24%).
(b) Representative photographs showing immunohistochemical staining of CypA in synovial tissues of control and CIA mice (left and middle
panel, respectively; n = 4 mice in each group). Right panel (negative control) showing immunohistochemical staining of CypA in synovial tissues
of CIA mice according to the method described above, except that the primary antibody was omitted. (c,d) Representative western blots of CypA
in the conditioned medium (c: top panel) and in the cell lysates (d) of FLS culture treated with vehicle and LPS (100 ng/mL for 24 h). β-actin was
used as an internal control. Densitometric analysis was performed on protein bands and the data are expressed as the percentage of vehicle
values. Each bar indicates mean ± S.E.M. (n = 5) *P < 0.05, significantly different from vehicle (c: bottom panel). Three separate experiments (n = 2
dishes in each) were performed (vehicle: 100.0 ± 1.0%, LPS: 104.9 ± 1.9%) (d).
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Values are expressed as the mean ± S.E.M. Statistical
analysis was performed using a Student’s t test or one
way analysis of variance followed by Dunnett’s post hoc
test. The differences between the means were considered
to be significant at P < 0.05.
Results and discussion
Immunoblotting and immunohistochemical analysis
showed that CypA was highly expressed in the joints of
CIA mice compared with control mice (Figure 1a and b,
respectively). This finding is consistent with a report of
Damsker et al. [14]; these support the clinical evidence
that elevated levels of extracellular CypA have been
found in the synovial fluids of RA patients [9]. To inves-
tigate whether FLS isolated from CIA mice secreted
CypA, the conditioned media were obtained from FLS
cultures and analyzed by western blotting (Figure 1c).
FLS isolated from CIA mice were found to secreteCypA. CypA enhances the secretion of MMP-2 and
MMP-9, cell invasion, and production of inflammatory
cytokines in monocytes [16]. These findings suggest that
increased CypA in the synovial fluid may have a role in
RA development.
When FLS were stimulated with lipopolysaccharide
(LPS), CypA secretion was significantly increased to
170.5 ± 46.2% of control FLS (vehicle). LPS had no effect
on the intracellular levels of CypA in FLS (Figure 1d).
Toll-like receptor 4 (TLR4), a receptor for LPS, is highly
expressed in the synovial tissue of RA patients [17].
Mice defective in Tlr4 are protected from experimental
arthritis [18], and TLR4 inhibitors ameliorate destruc-
tive arthritis in mice [19]. Furthermore, endogenous
TLR4 ligands, including heat shock proteins, tenascin-
C, and S100 proteins, are expressed in the rheumatoid
joints [20-22]. These findings suggest that endogenous















Figure 2 CD147 expression in the synovial tissues of CIA mice. (a) Representative western blots of CD147 levels in tissue lysates of the
synovial joints of control and CIA mice. GAPDH was used as an internal control. Densitometric analysis was performed on protein bands and the
data are expressed as the percentage of control values. Three separate experiments (n = 3 mice in each) were performed (control: 100.0 ± 17.4%,
CIA: 1144.2 ± 125.1%). (b) Representative photographs showing immunohistochemical staining of CD147 in synovial tissues of control and CIA
mice (left and middle panel, respectively; n = 4 mice in each group). Right panel (negative control) showing immunohistochemical staining of
CD147 in synovial tissues of CIA mice according to the method described above, except that the primary antibody was omitted. (c)
Representative photographs showing immunohistochemical staining of CD147 in infiltrated CD11b-immunopositive cells (mainly for
macrophages) of synovial tissues of control and CIA mice (top and middle panel, respectively; n = 4 mice in each group). Frozen joints sections
were stained with antibodies for CD11b (green) and CD147 (red) for double immunofluorescence staining. Bottom panel (negative control)
showing double immunofluorescence staining of CD11b and CD147 in synovial tissues of CIA mice according to the method described above,
except that the primary antibodies were omitted.
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http://www.journal-inflammation.com/content/9/1/44As shown in Figure 2, band intensities (a) and immu-
noreactivities (b) for CD147 were markedly increased in
the joints of CIA mice. Elevated CD147 expression is
shown in the synovial membrane of RA patients (16),
and CD147 stimulates MMP production in the synovial
tissue of affected joints in RA patients (17). The synovial
tissues of CIA mice showed abundant staining of
CD11b, mainly for macrophages (data not shown). Based
on their distribution pattern and histological shape,
these CD147-immunoreactive cells were identified as
potentially being macrophages. We investigated the
localization of CD147 in macrophages in the synovial
sections using antibodies for CD147 and CD11b. The
immunoreactivities for CD147 were found to co-localize
with those for CD11b in CIA synovial tissues
(Figure 2c). CD11b is expressed on leukocytes including
macrophages, granulocytes and NK cells. In our double
immunofluorescence staining of the joints of mice with
CIA, co-localization of CD147 and infiltrated macro-
phages could not be detected by using other mouse




















Figure 3 Effect of CypA on CD147 expression by cultured mouse mac
for 24 h. Representative western blots (top panel) and densitometric analysis (bo
internal control. Band intensities were quantified by scanning densitometry and
treatment (vehicle). Values are the means ± S.E.M. (n= 7) *P< 0.05, significantly dbackground. The primary culture of macrophages was
exposed to CypA for 24 h. Representative western blots
for CD147 (top panel) and densitometry analysis for
these intensities (bottom panel) showed that CypA (100,
200 and 500 ng/mL) dose-dependently increased CD147
levels by 121.5 ± 5.6, 133.0 ± 7.5 and 133.4 ± 14.8%, re-
spectively (Figure 3). CypA is frequently used at concen-
trations ranging from 100 to 1000 ng/mL. In the present
study, CypA (200 and 500 ng/mL) increased CD147 ex-
pression in macrophages. The concentration of CypA
employed in the current study is within the range fre-
quently used in in vitro studies, although we did not de-
termine the concentration of CypA in the joints of CIA
mice. CypA-induced CD147 expression in macrophages
is an entirely novel finding in the present study. There
was a considerable increase in CD147 expression in CIA
synovial tissue (Figure 2c). However, the effect of CypA
on macrophages was modest, with an approximate max-
imum increase of 30% (Figure 3). Therefore, it is likely
that the increase in CD147 expression in infiltrated





rophages. Macrophage cultures were treated with CypA (100–500 ng/mL)
ttom panel) of CD147 in the cultured macrophages. β-actin was used as an
the data are expressed as relative ratio of CypA treatment to vehicle
ifferent from vehicle.
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tors, including CypA. It has been known that CypA is a
paracrine and autocrine modulator of endothelial cell
function in vascular disease [5]. CD147 expression in
monocytes/macrophages in RA synovium is much
higher than that in those cells derived from peripheral
blood of RA patients [23]. We used two strains of mice
in the current study. DBA/1J mice are well known to be
the most sensitive to the induction of CIA. C57BL/6N
mice were used for the experiment with isolated bone
marrow-derived macrophages because of the convenient
purchase and cost in our university. As shown in
Figure 1, CypA expression in synovial tissues and CypA
secretion from FLS were observed in CIA mice (DBA/1J
strain). These mice showed increased expression of
CD147 in infiltrated macrophages of synovial tissues.
Therefore, our findings strongly suggest that CypA is
required for increased expression of CD147 in macro-
phages isolated from DBA/1J mice in a similar manner
to C57BL/6N mice (Figure 3). These findings suggest
that CypA secreted from FLS stimulates macrophages to
express CD147 in the RA synovium. Therefore, an inter-
action in the synovial joints between extracellular CypA
and CD147 on macrophages may be involved in the
mechanisms underlying the development of arthritis.
Regulation of CypA secretion and CD147 expression in
the synovial joints could be potential therapeutic targets
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